Pharmafile Logo
Pharmafocus logo
Advanced Search
Cirrus

Cirrus – a new name for specialist artwork services

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Multi Packaging Solutions (“MPS”), a global leader in value-added print and packaging solutions for the pharmaceutical, healthcare and FMCG sectors, …

News
Press release
sanofi-dr-frank-nestle-250

New immunology and inflammation research global head and North American CSO for Sanofi

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, appointment

Sanofi has announced the appointment of Dr Frank Nestle as both the global head of immunology and inflammation research therapeutic …

Appointment
eli_lilly_logo

Levi Garraway to succeed Richard Gaynor as senior VP of Global Oncology at Lilly

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, appointment

Eli Lilly has announced that Dr Levi Garraway will join the company as its senior vice president, Global Development & …

Appointment
allergan

Allergan snaps up Vitae Pharma for $639 million

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Vitae, acquisition

Allergan has agreed to buy clinical-stage biotech Vitae Pharmaceuticals for $639 million, or $21 a share – more than double …

News
c_nito_-_fotolia

UK Biopharma and life after Brexit

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit

Originally published in the September issue of Pharmafocus, Paul Ranson of global law firm Morgan Lewis’ London Life Sciences Practice …

Feature
hero-plus

Mylan CEO to appear before US congress over EpiPen scandal

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Hilary Clinton, Mylan, epipen

Following the controversy of Mylan’s price increases to its EpiPen (epinephrine) auto-injector, the company’s CEO Heather Bresch is due to …

News
gsk-house-location-building

GSK’s shingles vaccine tops MSD rival in Ph III testing

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

GlaxoSmithKline’s shingles vaccine Shingrix has topped rival MSD treatment Zostavax as it is shown to remain effective in elderly patients …

News
eisa0001

EU approval for Eisai kidney cancer treatment

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Afinitor, Eisai, Kisplyx, Lenvima, everolimus

The European Commission has approved the use of Eisai’s Kisplyx (lenvatinib) for the treatment of renal cell carcinoma (RCC) following …

News

Bayer acquires Monsanto in largest-ever deal by a German company

September 14, 2016
Business Services, Manufacturing and Production, Sales and Marketing Bayer, acqusition, monsanto

Bayer and Monsanto have signed a definitive merger agreement under which the German drugmaker will acquire the US agricultural group …

News
sanofi_hq__boetie_hall

Sanofi reveals promising data for FDA-delayed diabetes drug

September 14, 2016
Research and Development, Sales and Marketing FDA, Lantus, Sanofi, iglarlixi

Sanofi has announced new Phase III data for its IGlarLixi combination drug for the treatment of diabetes, showing it could …

News

Bayer raises bid yet again to finalise Monsanto deal

September 14, 2016
Manufacturing and Production, Research and Development, Sales and Marketing

Bayer has taken yet another step in its dedicated efforts to acquire Monsanto as it raises its offer to $129 …

News
images

Roche’s Ocrevus more effective than Merck’s Rebif, company claims

September 14, 2016
Research and Development Merck, Ocrevus, Rebif, Roche, multiple sclerosis

Roche has announced new results from the Phase III studies of investigational medicine Ocrevus (ocrelizumab) studying relapsing multiple sclerosis (RMS) …

News
entrance_takeda_i020_v1

Takeda reportedly sets $15bn on US acquisitions

September 14, 2016
Manufacturing and Production, Research and Development Takeda, acquisitions

Takeda Pharmaceuticals is reportedly willing to spend as much as $15 billion on acquisitions in the US in efforts to …

News
shutterstock_168864905

Novartis joins $17m funding of chronic inflammatory disease startup

September 14, 2016
Research and Development Fountain Healthcare, Novartis, start up financing

Novartis was one of the co-leaders in the $17million series A financing of Irish startup in the development of chronic …

News
rick_farris

ClinTec appoints Rick Farris as executive vice president of North American Operations

September 13, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ClinTec, appointment

Clinical research organisation ClinTec has announced the expansion of its US management team with the selection of Rick Farris as …

Appointment
eisa0008

Eisai reveals new long-term seizure control data at ECE 2016

September 13, 2016
Manufacturing and Production, Research and Development Eisai, epilepsy

Eisai has revealed new data on long-term seizure control in different seizure types at the 12th European Congress on Epileptology …

News
gsk_hq_close

GSK and J&J file rheumatoid arthritis treatment sirukumab in EU

September 13, 2016
Manufacturing and Production, Sales and Marketing GSK, GlaxoSmithKline, Johnson & Johnson, rheumatoid arthritis, sarilumab, sirukumab

GlaxoSmithKline and partner Johnson & Johnson’s Janssen Biologics unit have filed for approval of rheumatoid arthritis (RA) treatment sirukumab in …

News
web_scientist-filling-out-form---credit-national-institutes-of-health

Proteomics market to grow to $24.8 billion by 2024

September 13, 2016
Manufacturing and Production, Research and Development Grand View Research, proteomics

The global proteomics market is predicted to grow to exceed $24.8 billion by 2024, according to a new report by …

News
takeda_world

Takeda forms “first of its kind” developmental partnership with CRO

September 13, 2016
Manufacturing and Production, Research and Development PRA Health Services, Takeda, partnership

Takeda and PRA Health Services have announced a new partnership that will see the Japanese pharma giant transfer 300 staffers …

News
shutterstock_273326141

Horizon buys out Raptor for $800 million

September 13, 2016
Manufacturing and Production, Sales and Marketing Horizon Pharma, Raptor Pharmaceutical, acquisition

Irish biopharmaceutical firm Horizon Pharma has finalised an $800 million deal to buy Raptor Pharmaceutical Corp in a bid to …

News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026